| Financial Year |
March 31 2023 |
| Monetary Funds |
723,374,852.52 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
57,102,406.22 |
| Accounts Receivable |
52,512,779.37 |
| Advances to Suppliers |
227,426,776.73 |
| Other Receivables |
3,147,493.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
561,924,811.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
83,305,230.03 |
| Total Current Assets |
1,980,021,975.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,143,855.42 |
| Investment Properties |
-- |
| Fixed Assetes |
2,231,261,260.38 |
| Under-construction Projects |
1,195,107,724.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
565,202,995.08 |
| R&D expenses |
-- |
| Goodwill |
41,812,150.21 |
| Long-Term Deferred and Prepaid Expenses |
6,053,480.18 |
| Deferred Income Tax Assets |
77,228,633.80 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
4,133,810,099.82 |
| Total Assets |
6,113,832,074.88 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,113,575.11 |
| Accounts Payable |
361,158,463.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,968,513.20 |
| Taxes Payable |
4,847,734.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,741,356.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
62,762,900.36 |
| Sub-Total of Current Liabilities |
666,704,447.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
45,318,031.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
74,719,375.03 |
| Total Liabilities |
741,423,822.20 |
| Paid-In Capital(Or Share Stock) |
1,167,842,884.00 |
| Capital Surplus |
2,390,773,824.02 |
| Surplus Reserve |
353,364,767.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,458,050,670.41 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,372,408,252.68 |
| Owner's Equity（Stockholder's Equity） |
5,372,408,252.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,113,832,074.88 |
